Comparison of adherent and nonadherent groups
| Parameter | Adherent group | Nonadherent group |
| Duration of treatment months | 32 | 33 (p=0.55) |
| Baseline FEV1 % predicted | 55.0 | 61.95 (p=0.26) |
| Current FEV1 % predicted | 65.71 | 69.85 (p=0.39) |
| Baseline ACQ-7 score | 3.85 | 2.85 (p=0.40) |
| Current ACQ-7 score | 2.36 | 1.79 (p=0.067) |
| BDP equivalent ICS dose μg | 2000 | 1600 (p=0.04) |
| Current FeNO ppb | 15 | 22 (p=0.048) |
| Blood eosinophil count ×109 per L | 0.08 | 0.18 (p=0.09) |
FEV1: forced expiratory volume in 1 s; ACQ-7: Asthma Control Questionnaire 7; BDP: beclometasone; ICS: inhaled corticosteroid; FeNO: exhaled nitric oxide fraction.